SlideShare a Scribd company logo
Measuring medicine prices,  availability, affordability  and price components Margaret Ewen Health Action International
WHO/HAI Project on Medicine  Prices and Availability improve the availability and  affordability of essential medicines   Develop a reliable methodology for collecting and analysing price and availability data across healthcare sectors in a country Price transparency; survey data on a freely accessible website allowing international comparisons  Advocate for appropriate pricing policies and programmes, and monitor their impact
Measures medicine prices  availability  affordability  component costs Revision based on the  experiences of 55+ surveys  undertaken in all regions of  the world Survey tools and data: www.haiweb.org/medicineprices Second edition of the WHO/HAI survey manual Available now
What’s new in the manual? Methodology changes – sampling, medicines,  measuring price components New guidance on international comparisons,  policy options, advocacy and monitoring Expanded workbook & new resources Regional workshops on new manual & tools 2008: Anglophone Africa, Eastern Mediterranean, Asia 2009: Francophone Africa, possibly other regions WHO/HAI and international pricing policy experts Developing guidance on policies that affect medicine  prices and their impact in various settings

More Related Content

What's hot

How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
Office of Health Economics
 
Towse us and eu comparison slides
Towse us and eu comparison slidesTowse us and eu comparison slides
Towse us and eu comparison slides
Office of Health Economics
 
PRIME
PRIMEPRIME
HCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike SchadeHCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike Schade
Chemicals Forum Association
 
Multi-Indication Pricing: Pros, Cons and Applicability to the UK
Multi-Indication Pricing: Pros, Cons and Applicability to the UKMulti-Indication Pricing: Pros, Cons and Applicability to the UK
Multi-Indication Pricing: Pros, Cons and Applicability to the UK
Kerry Sheppard
 
HCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka MalmHCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka Malm
Chemicals Forum Association
 
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
Office of Health Economics
 
Enabling General Practice Transformation
Enabling General Practice TransformationEnabling General Practice Transformation
Enabling General Practice Transformation
Health Informatics New Zealand
 
Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...
Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...
Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...
John Blue
 
UNDP at The International Healthcare Waste Conference
UNDP at The International Healthcare Waste ConferenceUNDP at The International Healthcare Waste Conference
UNDP at The International Healthcare Waste Conference
UN SPHS
 
The SPHS Presentation at The International Water Association Conference in Sw...
The SPHS Presentation at The International Water Association Conference in Sw...The SPHS Presentation at The International Water Association Conference in Sw...
The SPHS Presentation at The International Water Association Conference in Sw...
UN SPHS
 
UNDP at the International conference on Obsolete Pharmaceuticals: Impact on ...
UNDP at the International conference  on Obsolete Pharmaceuticals: Impact on ...UNDP at the International conference  on Obsolete Pharmaceuticals: Impact on ...
UNDP at the International conference on Obsolete Pharmaceuticals: Impact on ...
UN SPHS
 
June 9 2017 Panel 4 Anne Gourmelon
June 9 2017 Panel 4 Anne GourmelonJune 9 2017 Panel 4 Anne Gourmelon
June 9 2017 Panel 4 Anne Gourmelon
Chemicals Forum Association
 
Opportunity costs and local health service spending decisions: A qualitative ...
Opportunity costs and local health servicespending decisions: A qualitative ...Opportunity costs and local health servicespending decisions: A qualitative ...
Opportunity costs and local health service spending decisions: A qualitative ...
Kerry Sheppard
 
Interagency Approach to Sustainable Procurement in Health Sector
Interagency Approach to Sustainable Procurement in Health SectorInteragency Approach to Sustainable Procurement in Health Sector
Interagency Approach to Sustainable Procurement in Health Sector
UNDP Eurasia
 
Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...
Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...
Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...
Forest Research
 
Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...
Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...
Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...
VICTOR MAESTRE RAMIREZ
 
Increasing Numbers of Launches and Growth in Spending on Specialty Products i...
Increasing Numbers of Launches and Growth in Spending on Specialty Products i...Increasing Numbers of Launches and Growth in Spending on Specialty Products i...
Increasing Numbers of Launches and Growth in Spending on Specialty Products i...
IMS Health US
 
June 9 2017 Panel 4 Erika Kunz
June 9 2017 Panel 4 Erika KunzJune 9 2017 Panel 4 Erika Kunz
June 9 2017 Panel 4 Erika Kunz
Chemicals Forum Association
 
Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...
Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...
Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...
VICTOR MAESTRE RAMIREZ
 

What's hot (20)

How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
 
Towse us and eu comparison slides
Towse us and eu comparison slidesTowse us and eu comparison slides
Towse us and eu comparison slides
 
PRIME
PRIMEPRIME
PRIME
 
HCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike SchadeHCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike Schade
 
Multi-Indication Pricing: Pros, Cons and Applicability to the UK
Multi-Indication Pricing: Pros, Cons and Applicability to the UKMulti-Indication Pricing: Pros, Cons and Applicability to the UK
Multi-Indication Pricing: Pros, Cons and Applicability to the UK
 
HCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka MalmHCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka Malm
 
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
 
Enabling General Practice Transformation
Enabling General Practice TransformationEnabling General Practice Transformation
Enabling General Practice Transformation
 
Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...
Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...
Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...
 
UNDP at The International Healthcare Waste Conference
UNDP at The International Healthcare Waste ConferenceUNDP at The International Healthcare Waste Conference
UNDP at The International Healthcare Waste Conference
 
The SPHS Presentation at The International Water Association Conference in Sw...
The SPHS Presentation at The International Water Association Conference in Sw...The SPHS Presentation at The International Water Association Conference in Sw...
The SPHS Presentation at The International Water Association Conference in Sw...
 
UNDP at the International conference on Obsolete Pharmaceuticals: Impact on ...
UNDP at the International conference  on Obsolete Pharmaceuticals: Impact on ...UNDP at the International conference  on Obsolete Pharmaceuticals: Impact on ...
UNDP at the International conference on Obsolete Pharmaceuticals: Impact on ...
 
June 9 2017 Panel 4 Anne Gourmelon
June 9 2017 Panel 4 Anne GourmelonJune 9 2017 Panel 4 Anne Gourmelon
June 9 2017 Panel 4 Anne Gourmelon
 
Opportunity costs and local health service spending decisions: A qualitative ...
Opportunity costs and local health servicespending decisions: A qualitative ...Opportunity costs and local health servicespending decisions: A qualitative ...
Opportunity costs and local health service spending decisions: A qualitative ...
 
Interagency Approach to Sustainable Procurement in Health Sector
Interagency Approach to Sustainable Procurement in Health SectorInteragency Approach to Sustainable Procurement in Health Sector
Interagency Approach to Sustainable Procurement in Health Sector
 
Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...
Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...
Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...
 
Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...
Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...
Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...
 
Increasing Numbers of Launches and Growth in Spending on Specialty Products i...
Increasing Numbers of Launches and Growth in Spending on Specialty Products i...Increasing Numbers of Launches and Growth in Spending on Specialty Products i...
Increasing Numbers of Launches and Growth in Spending on Specialty Products i...
 
June 9 2017 Panel 4 Erika Kunz
June 9 2017 Panel 4 Erika KunzJune 9 2017 Panel 4 Erika Kunz
June 9 2017 Panel 4 Erika Kunz
 
Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...
Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...
Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...
 

Similar to Measuring Medicine Prices

Encouraging best practice and improve the rational use of medicines
Encouraging best practice and improve the rational  use of medicinesEncouraging best practice and improve the rational  use of medicines
Encouraging best practice and improve the rational use of medicines
MeTApresents
 
0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols
Workgroup of European Cancer Patient Advocacy Networks
 
Drug Purchasing & Pricing : industry perspective
Drug Purchasing & Pricing : industry perspectiveDrug Purchasing & Pricing : industry perspective
Drug Purchasing & Pricing : industry perspective
Pharmacy @ Institut Kanser Negara
 
EuroBioForum 2013 - Day 1 | Katherine Payne
 EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTA
MeTApresents
 
What can we learn from other countries?
What can we learn from other countries?What can we learn from other countries?
What can we learn from other countries?
Health and Care Innovation Expo
 
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
RDD 2020 Day 2 AM : Tania Stafinski
RDD 2020 Day 2 AM : Tania StafinskiRDD 2020 Day 2 AM : Tania Stafinski
RDD 2020 Day 2 AM : Tania Stafinski
Canadian Organization for Rare Disorders
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization Studies
Zarrin Ansari
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
Dr.Kavitha Vivek
 
Challenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in GhanaChallenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in Ghana
MeTApresents
 
Pharma premium pricing
Pharma premium pricingPharma premium pricing
Pharma premium pricing
Clearstate
 
Promotional drug literature
Promotional drug literature  Promotional drug literature
Promotional drug literature
bhagyamohod90
 
Patient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptxPatient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptx
DrVivekChauhan1
 
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
Canadian Organization for Rare Disorders
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
Dhruvi50
 
Vientiane Panel Oct08 Salmela V4
Vientiane Panel Oct08 Salmela V4Vientiane Panel Oct08 Salmela V4
Vientiane Panel Oct08 Salmela V4
IDS
 
Paying for performance to improve the delivery of health interventions in LMICs
Paying for performance to improve the delivery of health interventions in LMICsPaying for performance to improve the delivery of health interventions in LMICs
Paying for performance to improve the delivery of health interventions in LMICs
ReBUILD for Resilience
 
Pharmacovigilance & WHO Drug Monitoring Program.pptx
Pharmacovigilance & WHO Drug Monitoring Program.pptxPharmacovigilance & WHO Drug Monitoring Program.pptx
Pharmacovigilance & WHO Drug Monitoring Program.pptx
Easy Concept
 
DUS_Dr. Mansij Biswas
DUS_Dr. Mansij BiswasDUS_Dr. Mansij Biswas
DUS_Dr. Mansij Biswas
Mansij Biswas
 

Similar to Measuring Medicine Prices (20)

Encouraging best practice and improve the rational use of medicines
Encouraging best practice and improve the rational  use of medicinesEncouraging best practice and improve the rational  use of medicines
Encouraging best practice and improve the rational use of medicines
 
0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols
 
Drug Purchasing & Pricing : industry perspective
Drug Purchasing & Pricing : industry perspectiveDrug Purchasing & Pricing : industry perspective
Drug Purchasing & Pricing : industry perspective
 
EuroBioForum 2013 - Day 1 | Katherine Payne
 EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine Payne
 
Concept and structure of MeTA
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTA
 
What can we learn from other countries?
What can we learn from other countries?What can we learn from other countries?
What can we learn from other countries?
 
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
 
RDD 2020 Day 2 AM : Tania Stafinski
RDD 2020 Day 2 AM : Tania StafinskiRDD 2020 Day 2 AM : Tania Stafinski
RDD 2020 Day 2 AM : Tania Stafinski
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization Studies
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Challenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in GhanaChallenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in Ghana
 
Pharma premium pricing
Pharma premium pricingPharma premium pricing
Pharma premium pricing
 
Promotional drug literature
Promotional drug literature  Promotional drug literature
Promotional drug literature
 
Patient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptxPatient_Care_Process_Template_Presentation-Final.pptx
Patient_Care_Process_Template_Presentation-Final.pptx
 
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
 
Vientiane Panel Oct08 Salmela V4
Vientiane Panel Oct08 Salmela V4Vientiane Panel Oct08 Salmela V4
Vientiane Panel Oct08 Salmela V4
 
Paying for performance to improve the delivery of health interventions in LMICs
Paying for performance to improve the delivery of health interventions in LMICsPaying for performance to improve the delivery of health interventions in LMICs
Paying for performance to improve the delivery of health interventions in LMICs
 
Pharmacovigilance & WHO Drug Monitoring Program.pptx
Pharmacovigilance & WHO Drug Monitoring Program.pptxPharmacovigilance & WHO Drug Monitoring Program.pptx
Pharmacovigilance & WHO Drug Monitoring Program.pptx
 
DUS_Dr. Mansij Biswas
DUS_Dr. Mansij BiswasDUS_Dr. Mansij Biswas
DUS_Dr. Mansij Biswas
 

More from MeTApresents

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
MeTApresents
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The Philippines
MeTApresents
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
MeTApresents
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
MeTApresents
 
MeTA introduction
MeTA introductionMeTA introduction
MeTA introduction
MeTApresents
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core Principles
MeTApresents
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosure
MeTApresents
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in Zambia
MeTApresents
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in Zambia
MeTApresents
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in Uganda
MeTApresents
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reporting
MeTApresents
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendations
MeTApresents
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
MeTApresents
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in Jordan
MeTApresents
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestones
MeTApresents
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in Ghana
MeTApresents
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
MeTApresents
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein Kyrgyzstan
MeTApresents
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and future
MeTApresents
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance note
MeTApresents
 

More from MeTApresents (20)

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The Philippines
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
 
MeTA introduction
MeTA introductionMeTA introduction
MeTA introduction
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core Principles
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosure
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in Zambia
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in Zambia
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in Uganda
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reporting
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendations
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in Jordan
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestones
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in Ghana
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein Kyrgyzstan
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and future
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance note
 

Recently uploaded

Text Book of Critical Care Nursing ICU NURSING
Text Book of Critical Care Nursing  ICU NURSINGText Book of Critical Care Nursing  ICU NURSING
Text Book of Critical Care Nursing ICU NURSING
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
AGARICUS MUSCARIUS.pptx Keynotes by H.C. Allen
AGARICUS MUSCARIUS.pptx  Keynotes by H.C. AllenAGARICUS MUSCARIUS.pptx  Keynotes by H.C. Allen
AGARICUS MUSCARIUS.pptx Keynotes by H.C. Allen
DR.P.S SUDHAKAR
 
Text Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of NursingText Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of Nursing
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
THE MANAGEMENT OF PROSTATE CANCER . pptx
THE MANAGEMENT OF PROSTATE CANCER . pptxTHE MANAGEMENT OF PROSTATE CANCER . pptx
THE MANAGEMENT OF PROSTATE CANCER . pptx
Bright Chipili
 
anthelmintic-drugs.pptx pharmacology dep
anthelmintic-drugs.pptx pharmacology depanthelmintic-drugs.pptx pharmacology dep
anthelmintic-drugs.pptx pharmacology dep
sapnasirswal
 
Comfort, Rest, Sleep and Pain.pptx
Comfort, Rest, Sleep  and Pain.pptxComfort, Rest, Sleep  and Pain.pptx
Comfort, Rest, Sleep and Pain.pptx
Nandish Sannaiah
 
KUSTHA PPT .pdf KUSTHA definition, classification, and modern probable correl...
KUSTHA PPT .pdf KUSTHA definition, classification, and modern probable correl...KUSTHA PPT .pdf KUSTHA definition, classification, and modern probable correl...
KUSTHA PPT .pdf KUSTHA definition, classification, and modern probable correl...
DrMalathiVenketesham
 
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
Sarthi Life Sciences
 
Exploring Alternatives- Why Laparoscopy Isn't Always Best for Hydrosalpinx.pptx
Exploring Alternatives- Why Laparoscopy Isn't Always Best for Hydrosalpinx.pptxExploring Alternatives- Why Laparoscopy Isn't Always Best for Hydrosalpinx.pptx
Exploring Alternatives- Why Laparoscopy Isn't Always Best for Hydrosalpinx.pptx
FFragrant
 
Operation Theatre Nursing -History of Surgery & Anesthesia.pptx
Operation Theatre Nursing -History of Surgery & Anesthesia.pptxOperation Theatre Nursing -History of Surgery & Anesthesia.pptx
Operation Theatre Nursing -History of Surgery & Anesthesia.pptx
RadhaThapaChhetry
 
Drug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptxDrug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptx
drebrahiim
 
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Anindya Das Adhikary
 
Mainstreaming #CleanLanguage in healthcare.pptx
Mainstreaming #CleanLanguage in healthcare.pptxMainstreaming #CleanLanguage in healthcare.pptx
Mainstreaming #CleanLanguage in healthcare.pptx
Judy Rees
 
SA Gastro Cure(pancreatic cancer treatment in india).pptx
SA Gastro Cure(pancreatic cancer treatment in india).pptxSA Gastro Cure(pancreatic cancer treatment in india).pptx
SA Gastro Cure(pancreatic cancer treatment in india).pptx
VinothKumar70905
 
lessonplan JTR.pptx For medical education
lessonplan JTR.pptx For medical educationlessonplan JTR.pptx For medical education
lessonplan JTR.pptx For medical education
DrJALAGAMTHIRUPATHIR
 
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdfNUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
MatsikoAlex
 
Nursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysisNursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysis
shivalingatalekar1
 
Dr Charles James de Vis, M.R.C.S., L.S.A. England, Surgeon to the Charters To...
Dr Charles James de Vis, M.R.C.S., L.S.A. England, Surgeon to the Charters To...Dr Charles James de Vis, M.R.C.S., L.S.A. England, Surgeon to the Charters To...
Dr Charles James de Vis, M.R.C.S., L.S.A. England, Surgeon to the Charters To...
semualkaira
 
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Dr.Nishant Janu
 
Handbook of Dental anatomy (practical part)
Handbook of Dental anatomy (practical part)Handbook of Dental anatomy (practical part)
Handbook of Dental anatomy (practical part)
MuhammedMNasser
 

Recently uploaded (20)

Text Book of Critical Care Nursing ICU NURSING
Text Book of Critical Care Nursing  ICU NURSINGText Book of Critical Care Nursing  ICU NURSING
Text Book of Critical Care Nursing ICU NURSING
 
AGARICUS MUSCARIUS.pptx Keynotes by H.C. Allen
AGARICUS MUSCARIUS.pptx  Keynotes by H.C. AllenAGARICUS MUSCARIUS.pptx  Keynotes by H.C. Allen
AGARICUS MUSCARIUS.pptx Keynotes by H.C. Allen
 
Text Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of NursingText Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of Nursing
 
THE MANAGEMENT OF PROSTATE CANCER . pptx
THE MANAGEMENT OF PROSTATE CANCER . pptxTHE MANAGEMENT OF PROSTATE CANCER . pptx
THE MANAGEMENT OF PROSTATE CANCER . pptx
 
anthelmintic-drugs.pptx pharmacology dep
anthelmintic-drugs.pptx pharmacology depanthelmintic-drugs.pptx pharmacology dep
anthelmintic-drugs.pptx pharmacology dep
 
Comfort, Rest, Sleep and Pain.pptx
Comfort, Rest, Sleep  and Pain.pptxComfort, Rest, Sleep  and Pain.pptx
Comfort, Rest, Sleep and Pain.pptx
 
KUSTHA PPT .pdf KUSTHA definition, classification, and modern probable correl...
KUSTHA PPT .pdf KUSTHA definition, classification, and modern probable correl...KUSTHA PPT .pdf KUSTHA definition, classification, and modern probable correl...
KUSTHA PPT .pdf KUSTHA definition, classification, and modern probable correl...
 
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
 
Exploring Alternatives- Why Laparoscopy Isn't Always Best for Hydrosalpinx.pptx
Exploring Alternatives- Why Laparoscopy Isn't Always Best for Hydrosalpinx.pptxExploring Alternatives- Why Laparoscopy Isn't Always Best for Hydrosalpinx.pptx
Exploring Alternatives- Why Laparoscopy Isn't Always Best for Hydrosalpinx.pptx
 
Operation Theatre Nursing -History of Surgery & Anesthesia.pptx
Operation Theatre Nursing -History of Surgery & Anesthesia.pptxOperation Theatre Nursing -History of Surgery & Anesthesia.pptx
Operation Theatre Nursing -History of Surgery & Anesthesia.pptx
 
Drug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptxDrug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptx
 
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
 
Mainstreaming #CleanLanguage in healthcare.pptx
Mainstreaming #CleanLanguage in healthcare.pptxMainstreaming #CleanLanguage in healthcare.pptx
Mainstreaming #CleanLanguage in healthcare.pptx
 
SA Gastro Cure(pancreatic cancer treatment in india).pptx
SA Gastro Cure(pancreatic cancer treatment in india).pptxSA Gastro Cure(pancreatic cancer treatment in india).pptx
SA Gastro Cure(pancreatic cancer treatment in india).pptx
 
lessonplan JTR.pptx For medical education
lessonplan JTR.pptx For medical educationlessonplan JTR.pptx For medical education
lessonplan JTR.pptx For medical education
 
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdfNUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
 
Nursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysisNursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysis
 
Dr Charles James de Vis, M.R.C.S., L.S.A. England, Surgeon to the Charters To...
Dr Charles James de Vis, M.R.C.S., L.S.A. England, Surgeon to the Charters To...Dr Charles James de Vis, M.R.C.S., L.S.A. England, Surgeon to the Charters To...
Dr Charles James de Vis, M.R.C.S., L.S.A. England, Surgeon to the Charters To...
 
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
Gestational Trophoblastic Disease( GTD)- Molar pregnancy, Gestational Trophob...
 
Handbook of Dental anatomy (practical part)
Handbook of Dental anatomy (practical part)Handbook of Dental anatomy (practical part)
Handbook of Dental anatomy (practical part)
 

Measuring Medicine Prices

  • 1. Measuring medicine prices, availability, affordability and price components Margaret Ewen Health Action International
  • 2. WHO/HAI Project on Medicine Prices and Availability improve the availability and affordability of essential medicines Develop a reliable methodology for collecting and analysing price and availability data across healthcare sectors in a country Price transparency; survey data on a freely accessible website allowing international comparisons Advocate for appropriate pricing policies and programmes, and monitor their impact
  • 3. Measures medicine prices availability affordability component costs Revision based on the experiences of 55+ surveys undertaken in all regions of the world Survey tools and data: www.haiweb.org/medicineprices Second edition of the WHO/HAI survey manual Available now
  • 4. What’s new in the manual? Methodology changes – sampling, medicines, measuring price components New guidance on international comparisons, policy options, advocacy and monitoring Expanded workbook & new resources Regional workshops on new manual & tools 2008: Anglophone Africa, Eastern Mediterranean, Asia 2009: Francophone Africa, possibly other regions WHO/HAI and international pricing policy experts Developing guidance on policies that affect medicine prices and their impact in various settings